Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jérémie Mariau"'
Autor:
Mohamed Abdelkarim, Nadejda Vintonenko, Anna Starzec, Aniela Robles, Julie Aubert, Marie-Laure Martin, Samia Mourah, Marie-Pierre Podgorniak, Sylvie Rodrigues-Ferreira, Clara Nahmias, Pierre-Olivier Couraud, Christelle Doliger, Odile Sainte-Catherine, Nicole Peyri, Lei Chen, Jérémie Mariau, Monique Etienne, Gerard-Yves Perret, Michel Crepin, Jean-Luc Poyet, Abdel-Majid Khatib, Mélanie Di Benedetto
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23334 (2011)
INTRODUCTION: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM) environment
Externí odkaz:
https://doaj.org/article/bf19b55f1bfd4906addabfd515120808
Autor:
Hang-Phuong Pham, Philippe Seksik, Beatrice Banneville, Olivier Chazouillères, Fabien Pitoiset, Julien Champey, Bruno Fautrel, David Saadoun, Laurent Beaugerie, Valérie Doppler, Patrice Cacoub, Karim El Soufi, Selim Aractingi, Christophe Corpechot, Roberta Lorenzon, David Klatzmann, Michelle Rosenzwajg, Francis Berenbaum, Claude C.A. Bernard, Eric Vicaut, Jérémie Mariau, Elodie Regnier, Joe-Elie Salem, Anne Daguenel-Nguyen, Jérémie Sellam, Arsène Mekinian, Claire Ribet
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2018, pp.annrheumdis-2018-214229
Annals of the Rheumatic Diseases, 2019, 78 (2), pp.209-217. ⟨10.1136/annrheumdis-2018-214229⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 78 (2), pp.209-217. ⟨10.1136/annrheumdis-2018-214229⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, pp.annrheumdis-2018-214229
Annals of the Rheumatic Diseases, 2018, pp.annrheumdis-2018-214229
Annals of the Rheumatic Diseases, 2019, 78 (2), pp.209-217. ⟨10.1136/annrheumdis-2018-214229⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, 78 (2), pp.209-217. ⟨10.1136/annrheumdis-2018-214229⟩
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, pp.annrheumdis-2018-214229
ObjectiveRegulatory T cells (Tregs) prevent autoimmunity and control inflammation. Consequently, any autoimmune or inflammatory disease reveals a Treg insufficiency. As low-dose interleukin-2 (ld-IL2) expands and activates Tregs, it has a broad thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a6de4db20c272b6fac7bc97852cf96
https://hal.sorbonne-universite.fr/hal-01960735
https://hal.sorbonne-universite.fr/hal-01960735
Autor:
Clara Nahmias, Marie-Pierre Podgorniak, Sylvie Rodrigues-Ferreira, Abdel-Majid Khatib, Nicole Peyri, Julie Aubert, Nadejda Vintonenko, Michel Crépin, Lei Chen, Anna Starzec, Mélanie Di Benedetto, Pierre-Olivier Couraud, Christelle Doliger, Odile Sainte-Catherine, Gérard-Yves Perret, Jean-Luc Poyet, Aniela Robles, Jérémie Mariau, Monique Etienne, Marie-Laure Martin, Mohamed Abdelkarim, Samia Mourah
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2011, 6 (8), pp.e23334. ⟨10.1371/journal.pone.0023334⟩
PLoS ONE, Vol 6, Iss 8, p e23334 (2011)
Plos One 8 (6), 1-13. (2011)
PLoS ONE, Public Library of Science, 2011, 6 (8), pp.e23334. ⟨10.1371/journal.pone.0023334⟩
PLoS ONE, Vol 6, Iss 8, p e23334 (2011)
Plos One 8 (6), 1-13. (2011)
1 - Article; Introduction: The poor efficacy of various anti-cancer treatments against metastatic cells has focused attention on the role of tumor microenvironment in cancer progression. To understand the contribution of the extracellular matrix (ECM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357a24c048e6a1a4250c97193a273a37
https://hal.archives-ouvertes.fr/hal-00705949/file/journal.pone.0023334_1.pdf
https://hal.archives-ouvertes.fr/hal-00705949/file/journal.pone.0023334_1.pdf